Health services · LSTA

CALADRIUS BIOSCIENCES, INC.

12 filings mentioning 9 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
9topics disclosed
Health servicesindustry
NJbased in

Across 12 filings we hold, CALADRIUS BIOSCIENCES, INC. has written down 9 of the topics we track. That places it 3 of 22 companies we hold in health services, by how much we have collected.

LSTA Health services

What this obligates

Every instrument in our corpus that governs something CALADRIUS BIOSCIENCES, INC. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents29
ISO 3700126
GDPR26
ISO/IEC 27701:201921
Colorado Artificial Intelligence Act (proposed SB 24-205)16

10 frameworks, 379 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Internal Control8
Material Weakness2
Restatement2
Consent Order2
Enforcement Action2
Ransomware1
Regulatory Reporting1
Artificial Intelligence1
Data Breach1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control82026-03-09
Material Weakness22022-04-27
Restatement22022-09-15
Consent Order22026-05-29
Enforcement Action22026-05-29
Ransomware12022-03-22
Regulatory Reporting12024-02-29
Artificial Intelligence12025-11-06
Data Breach12026-03-09

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-05-298-KEntry into a material agreement, Financial statements and exhibitsfiling
2026-03-098-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2025-11-068-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-02-2910-Kfiling
2022-09-158-KCompletion of an acquisition, Item 3.03, Director or officer departurefiling
2022-04-278-KEntry into a material agreement, Regulation FD disclosure, Other material eventfiling
2022-03-2210-Kfiling
2021-06-048-KEntry into a material agreement, Financial statements and exhibitsfiling
2021-01-258-KEntry into a material agreement, Item 3.02, Other material eventfiling
2020-07-108-KEntry into a material agreement, Item 3.02, Financial statements and exhibitsfiling
2020-05-268-KEntry into a material agreement, Item 3.02, Financial statements and exhibitsfiling
2020-04-248-KEntry into a material agreement, Item 3.02, Financial statements and exhibitsfiling

Others in health services

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
DVADAVITA INC.12compare →
CCELCRYO CELL INTERNATIONAL INC12compare →
MRAIMarpai, Inc.12compare →
AGLagilon health, inc.12compare →
SHCSotera Health Co12compare →
CHConvey Health Solutions Holdings, Inc.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of health services · All companies · Today's edition